As we observe World Malaria Day on April 25, let’s take a look at some of the latest progress and new treatments against malaria. The post What are biotech companies doing to tackle malaria? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more

Find out what the ten most expensive drugs in the world currently are, as several gene therapies top the list. The post 8 of the most expensive drugs in biopharma: Unraveling the costliest medications appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more

A more advanced form of IL-2 cytokine therapy called IL-2 smart cytokines could overcome side effects, and shake up cancer care as we know it. The post Overcoming toxicities: are IL-2 smart cytokines the next big thing? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the origi ..read more

Unlock the power of complex innovative designs to tackle rare disease clinical trial challenges efficiently. The post Addressing rare disease clinical trial challenges: The power of complex innovative designs appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more

The companies Mirador Therapeutics, Alumis, and Sionna Therapeutics bagged the biggest private biotech investments in March 2024. The post The biggest private biotech investments in March 2024 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more

Building a career in biotech can be a daunting task without the right skills. Delve into the strategies to improve and leverage them. The post What are the necessary skills to work in the biotech industry and how to leverage them? appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction t ..read more

Dive into 2024's biotech investment strategies with RTW Investments on our podcast. Discover trends shaping the landscape ahead." The post The biotech investment landscape in 2024 appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more

Delve into the ongoing controversy involving the Chinese company WuXi AppTec and the possible impact on U.S. national security measures. The post Biotech under surveillance: The global impact of the WuXi AppTec controversy appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the or ..read more

Check out five RNA editing companies on a mission to find a safer alternative to traditional gene editing techniques. The post 5 RNA editing companies you should know about appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more

Find out more about small-molecule drugs, including how they work and what their advantages and disadvantages are. The post Small but mighty: The role of small-molecule drugs in disease treatment appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content ..read more